Dark

RIGL
Rigel Pharmaceuticals
stock NASDAQ

At Close

9/28/2023 3:59:30 PM EDT

1.11USD-0.893%(-0.01)829,458

1.10Bid 1.12Ask 0.02Spread IEX

Pre-market

9/25/2023 9:00:30 AM EDT

1.08USD-3.563%(-0.04)0

After-hours

9/28/2023 4:00:30 PM EDT

1.12USD+0.901%(+0.01)0

Overview Option Chain HistoricalMore

open chart

Market Cap

193.544M

CEO

Raul Rodriguez

Headquarters

South San Francisco, California, USA

Industry

Biotechnology

Next Earnings

2023-11-09 (42d)

Last Split

2003-06-251for9.0001reverse

AMGN SGMO INFI AZN CCXI ARDM MYL INVA XLV

RIGL Stats

Avg. Vol. 10 Day

924,359

Avg. Vol. 30 Day

906,087

Employees

155

Market Cap

193,544,357

Shares Out.

174,364,286

Float

142,165,383

P/E Ratio

-5.03

EPS (ttm)

-0.218

On/Off Exchange

42%/58%

6 Month Beta

1.33

1 Year Beta

0.80

2 Year Beta

1.23

3 Year Beta

1.23

52 Week Low

0.67

52 Week High

2.04

SMA50

1.14

SMA200

1.30

1 Week

-0.89%

1 Month

-6.33%

3 Month

-19.57%

6 Month

-18.38%

1 Year

-9.02%

2 Year

-69.59%

5 Year

-65.42%

Profile

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.

RIGL Stock Summary

Rigel Pharmaceuticals (NASDAQ:RIGL) stock price today is $1.11, and today's volume is 829,458. RIGL is down -0.893% today. The 30 day average volume is 906,087. RIGL market cap is 193.544M with 174,364,286 shares outstanding.

document.getElementById("hqHSDz").onerror = function(){this.style.display='none';}; .dark-mode .kxnYy1{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .kxnYy1{ color: #333333; background-color: white; border: 2px solid #333333; }RIGLRigel Pharmaceuticalsstock NASDAQ

RIGL Stock Summary

RIGL
Rigel Pharmaceuticals
stock NASDAQ